As part of bone marrow transplantation protocols, the cytokine granulocyte-colony stimulating factor (G-CSF) is repeatedly administrated clinically in order to stimulate stem cell mobilization from the bone marrow to the circulation. G-CSF treatments might act in part by disturbing cell-cell contact between bone marrow stromal cells.